Mantle cell lymphoma (MCL) is a type of non-Hodgkin's lymphoma (NHL),
comprising about 6% .... It is showing better complete remissions (CR) and
progression free survival (PFS) than CHOP regimen...
Mantle cell lymphoma (MCL) is considered incurable. Intensive
immunochemotherapy with stem cell support has not been tested in large,
About Mantle Cell Lymphoma. Mantle cell lymphoma (MCL) results from a
malignant ... Commonly seen complications from disease progression may
Jul 31, 2015 ... Mantle cell lymphoma (MCL) is a lymphoproliferative disorder ... An inexorable
pattern of progression is characteristic, with a median time to ...
Mantle-cell lymphoma (MCL) is known to have a poor outcome, however, most
patients .... Progression-free survival for 26 patients with limited-stage mantle-cell
Mar 2, 2015 ... Outcome of patients with mantle cell lymphoma who experience disease
progression following ibrutinib therapy is poor.
Feb 1, 2009 ... Recognition of mantle-cell lymphoma (MCL) in the 1994 Revised European-
American Lymphoma classification of lymphoid neoplasms as a ...
Jan 25, 2016 ... Ibrutinib is a marvelous addition to mantle cell lymphoma treatment ... time to
progression of 6 months, and median duration of response of 9 ...
Mantle cell lymphoma is an aggressive variety of lymphoma which is ... it has
been found that ARA-C adds a significant benefit to the progression free survival.
Jul 15, 2009 ... Mantle cell lymphoma (MCL) is a distinct subtype of non-Hodgkin ... Progress has
been made in MCL therapy in the past decade based on ...